Harpoon Therapeutics, Inc.

Home » Harpoon Therapeutics, Inc.

IPO

Harpoon Therapeutics, Inc.

We are a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases

Symbol

HARP

Final Price
$14.00

Final Shares
5,400,000

Effective Date
February 8, 2019

Underwriters
Citigroup, SVB Leerink Partners, Canaccord Genuity, Wedbush PacGrow

To view the prospectus for Harpoon Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253